NRGene Technologies Ltd

Tel Aviv Stock Exchange NRGN.TA

NRGene Technologies Ltd Operating Income for the year ending December 31, 2023: USD -5.28 M

NRGene Technologies Ltd Operating Income is USD -5.28 M for the year ending December 31, 2023, a 1.34% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • NRGene Technologies Ltd Operating Income for the year ending December 31, 2022 was USD -5.36 M, a 36.27% change year over year.
  • NRGene Technologies Ltd Operating Income for the year ending December 31, 2021 was USD -8.40 M, a -389.34% change year over year.
  • NRGene Technologies Ltd Operating Income for the year ending December 31, 2020 was USD -1.72 M, a 47.84% change year over year.
  • NRGene Technologies Ltd Operating Income for the year ending December 31, 2019 was USD -3.29 M, a 22.56% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
SV Wall Street
Tel Aviv Stock Exchange: NRGN.TA

NRGene Technologies Ltd

CEO Dr. Gil Ronen Ph.D.
IPO Date Jan. 31, 2021
Location Israel
Headquarters Golda Meir Street
Employees 50
Sector Consumers Staples
Industries
Agriculture Artificial Intelligence (AI) Big Data Biofuel Biotechnology Bread & Bakery Dairy & Milk Machinery
Description

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email